Back to Search
DAVID LEE, M.D.
M.D.
Medical Oncology Physician
NPI: 1437178746IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A82849(CA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
0101271846(VA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
NEW YORK MEDICAL COLLEGE
Class of 2001
Clinical Trials (3)
3
Linked Trials
0
Recruiting
2
With Results
Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention
NCT02511236COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy
NCT01661166COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Smoking Cessation in Hispanic Construction Workers
NCT02873377COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Cognitive behavioral therapy versus general health education for smoking cessation: A randomized controlled trial among diverse treatment seekers.
PMID 37141036·Psychol Addict Behav·2024
2-rct
Implementing a Novel Workplace Smoking Cessation Intervention Targeting Hispanic/Latino Construction Workers: A Pilot Cluster Randomized Trial.
PMID 33063570·Health Educ Behav·2021
2-rct
Integrating Worksite Smoking Cessation Services Into the Construction Sector: Opportunities and Challenges.
PMID 31426671·Health Educ Behav·2019
8-other
Reducing racial/ethnic tobacco cessation disparities via cognitive behavioral therapy: Design of a dualsite randomized controlled trial.
PMID 29617633·Contemp Clin Trials·2018
8-other
A cluster randomized pilot trial of a tailored worksite smoking cessation intervention targeting Hispanic/Latino construction workers: Intervention development and research design.
PMID 29454141·Contemp Clin Trials·2018
2-rct
Permeability of model stratum corneum lipid membrane measured using quartz crystal microbalance.
PMID 19435292·Langmuir·2009
7-preclinical
Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors.
PMID 19620271·CMAJ·2009
8-other
Adhesive dynamics simulations of the mechanical shedding of L-selectin from the neutrophil surface.
PMID 19486904·J Theor Biol·2009
8-other
"Dose-dependent" impact of recurrent cardiac events on mortality in patients with heart failure.
PMID 19100960·Am J Med·2009
8-other
High-radix microfluidic multiplexer with pressure valves of different thresholds.
PMID 19495450·Lab Chip·2009
8-other
Robotic prostatectomy: what we have learned and where we are going.
PMID 19430547·Yonsei Med J·2009
8-other
Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
PMID 19229860·J Cell Biochem·2009
8-other
Nonspherical colloidosomes with multiple compartments from double emulsions.
PMID 19373831·Small·2009
8-other
Targeted disruption of ROCK1 causes insulin resistance in vivo.
PMID 19276091·J Biol Chem·2009
7-preclinical
A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease.
PMID 19290777·Antioxid Redox Signal·2009
7-preclinical
Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging.
PMID 19520349·JACC Cardiovasc Imaging·2009
6-review
WeGAS: a web-based microbial genome annotation system.
PMID 19129632·Biosci Biotechnol Biochem·2009
8-other
Histone H4 is a major component of the antimicrobial action of human sebocytes.
PMID 19536143·J Invest Dermatol·2009
8-other
Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease.
PMID 19679656·J Biol Chem·2009
7-preclinical
Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.
PMID 19426838·Int Immunopharmacol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 7 locations total
- Address
- 4320 SEMINARY RD
ALEXANDRIA, VA 22304 - Phone
- (703) 504-3000
Locations (7)
Practice Location
4320 SEMINARY RD, ALEXANDRIA, VA
(703) 504-3000
Practice Location
8081 INNOVATION PARK DR, FAIRFAX, VA
(571) 472-4724
Practice Location
3600 JOSEPH SIEWICK DR, FAIRFAX, VA
(703) 391-3600
Practice Location
3300 GALLOWS RD, FALLS CHURCH, VA
(703) 776-4001
Practice Location
3200 KEARNEY STREET, FREMONT, CA
(510) 490-1222
Practice Location
44045 RIVERSIDE PKWY, LEESBURG, VA
(703) 858-6000
Practice Location
44055 RIVERSIDE PKWY STE 108, LEESBURG, VA
(703) 858-8600
Quick Facts
- NPI
- 1437178746
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 7
- Years in Practice
- 25
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile